Journal article
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
The Lancet (British edition), Vol.396(10258), pp.1223-1249
10/17/2020
DOI: 10.1016/S0140-6736(20)30752-2
PMCID: PMC7567026
PMID: 33069326
Abstract
Background Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease.
Methods GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the global level, regionally, and for 204 countries and territories. GBD uses a hierarchical list of risk factors so that specific risk factors (eg, sodium intake), and related aggregates (eg, diet quality), are both evaluated. This method has six analytical steps. (1) We included 560 risk-outcome pairs that met criteria for convincing or probable evidence on the basis of research studies. 12 risk-outcome pairs included in GBD 2017 no longer met inclusion criteria and 47 risk-outcome pairs for risks already included in GBD 2017 were added based on new evidence. (2) Relative risks were estimated as a function of exposure based on published systematic reviews, 81 systematic reviews done for GBD 2019, and meta-regression. (3) Levels of exposure in each age-sex-location-year included in the study were estimated based on all available data sources using spatiotemporal Gaussian process regression, DisMod-MR 2.1, a Bayesian meta-regression method, or alternative methods. (4) We determined, from published trials or cohort studies, the level of exposure associated with minimum risk, called the theoretical minimum risk exposure level. (5) Attributable deaths, YLLs, YLDs, and DALYs were computed by multiplying population attributable fractions (PAFs) by the relevant outcome quantity for each age-sex-location-year. (6) PAFs and attributable burden for combinations of risk factors were estimated taking into account mediation of different risk factors through other risk factors. Across all six analytical steps, 30 652 distinct data sources were used in the analysis. Uncertainty in each step of the analysis was propagated into the final estimates of attributable burden. Exposure levels for dichotomous, polytomous, and continuous risk factors were summarised with use of the summary exposure value to facilitate comparisons over time, across location, and across risks. Because the entire time series from 1990 to 2019 has been re-estimated with use of consistent data and methods, these results supersede previously published GBD estimates of attributable burden.
Findings The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure. Global declines also occurred for tobacco smoking and lead exposure. The largest increases in risk exposure were for ambient particulate matter pollution, drug use, high fasting plasma glucose, and high body-mass index. In 2019, the leading Level 2 risk factor globally for attributable deaths was high systolic blood pressure, which accounted for 10.8 million (95% uncertainty interval [UI] 9.51-12.1) deaths (19.2% [16.9-21.3] of all deaths in 2019), followed by tobacco (smoked, second-hand, and chewing), which accounted for 8.71 million (8.12-9.31) deaths (15.4% [14.6-16.2] of all deaths in 2019). The leading Level 2 risk factor for attributable DALYs globally in 2019 was child and maternal malnutrition, which largely affects health in the youngest age groups and accounted for 295 million (253-350) DALYs (11.6% [10.3-13.1] of all global DALYs that year). The risk factor burden varied considerably in 2019 between age groups and locations. Among children aged 0-9 years, the three leading detailed risk factors for attributable DALYs were all related to malnutrition. Iron deficiency was the leading risk factor for those aged 10-24 years, alcohol use for those aged 25-49 years, and high systolic blood pressure for those aged 50-74 years and 75 years and older.
Interpretation Overall, the record for reducing exposure to harmful risks over the past three decades is poor. Success with reducing smoking and lead exposure through regulatory policy might point the way for a stronger role for public policy on other risks in addition to continued efforts to provide information on risk factor harm to the general public. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd.
Details
- Title: Subtitle
- Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
- Creators
- Christopher J. L. Murray - University of WashingtonAleksandr Y. Aravkin - University of WashingtonPeng Zheng - University of WashingtonCristiana Abbafati - Univ Roma La Sapienza, Dept Jurid & Econ Studies, Rome, ItalyKaja M. Abbas - London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, EnglandMohsen Abbasi-Kangevari - Shahid Beheshti UniversityFoad Abd-Allah - Cairo UniversityAhmed Abdelalim - Cairo UniversityMohammad Abdollahi - University of TehranIbrahim Abdollahpour - Isfahan Univ Med Sci, Neurosci Res Ctr, Esfahan, IranKedir Hussein Abegaz - Near East UniversityHassan Abolhassani - University of TehranVictor Aboyans - Dupuytren Univ Hosp, Dept Cardiol, Limoges, FranceLucas Guimaraes Abreu - Federal ReserveMichael R. M. Abrigo - Philippine Inst Dev Studies, Dept Res, Quezon City, PhilippinesAhmed Abualhasan - Cairo UniversityLaith Jamal Abu-Raddad - Weill Cornell Med Coll Qatar, Dept Healthcare Policy & Res, Doha, QatarAbdelrahman I. Abushouk - Harvard UniversityMaryam Adabi - Hamadan Univ Med Sci, Hamadan, IranVictor Adekanmbi - Cardiff UniversityAbiodun Moshood Adeoye - Univ Coll Hosp, Sch Lab Med & Sci, Ibadan, NigeriaOlatunji O. Adetokunboh - Stellenbosch UniversityDavoud Adham - Ardabil Univ Med Sci, Sch Hlth, Ardebil, IranShailesh M. Advani - NIH, Social Behav Res Branch, Bldg 10, Bethesda, MD 20892 USAGina Agarwal - McMaster UniversitySeyed Mohammad Kazem Aghamir - University of TehranAnurag Agrawal - CSIR, Inst Genom & Integrat Biol, Delhi, IndiaTauseef Ahmad - Southeast UniversityKeivan Ahmadi - University of NottinghamMehdi Ahmadi - Ahvaz Jundishapur Univ Med Sci, Environm Hlth Engn, Ahvaz, IranHamid Ahmadieh - Shahid Beheshti UniversityMuktar Beshir Ahmed - Jimma UniversityTemesgen Yihunie Akalu - University of GondarRufus Olusola Akinyemi - University of IbadanTomi Akinyemiju - Duke UniversityBlessing Akombi - UNSW SydneyChisom Joyqueenet Akunna - Intercountry Ctr Oral Hlth ICOH Africa, Dept Publ Hlth, Jos, NigeriaFares Alahdab - Mayo Clin Fdn Med Educ & Res, Mayo Evidencebased Practice Ctr, Rochester, MN USAZiyad Al-Aly - Washington Univ, John T Milliken Dept Internal Med, St Louis, MO 63110 USAKhurshid Alam - Murdoch UniversitySamiah Alam - Dalhousie UniversityTahiya Alam - University of WashingtonFahad Mashhour Alanezi - Imam Abdulrahman Bin Faisal UniversityTurki M. Alanzi - Imam Abdulrahman Bin Faisal UniversityBiresaw Wassihun Alemu - Arba Minch UniversityKhalid F. Alhabib - King Saud UniversityMuhammad Ali - Quaid-i-Azam UniversitySaqib Ali - Sultan Qaboos UniversityGianfranco Alicandro - Italian Natl Inst Stat, Directorate Social Stat & Populat Census, Rome, ItalyCyrus Alinia - Urmia UniversityVahid Alipour - Iran Univ Med Sci, Hlth Econ Dept, Tehran, IranHesam Alizade - University of HormozganSyed Mohamed Aljunid - Kuwait UniversityFrancois Alla - Univ Bordeaux, Bordeaux Sch Publ Hlth, Bordeaux, FrancePeter Allebeck - Karolinska InstitutetAmir Almasi-Hashiani - Arak UniversityHesham M. Al-Mekhlafi - Jazan UniversityJordi Alonso - Universitat Pompeu FabraKhalid A. Altirkawi - King Saud UniversityMostafa Amini-Rarani - Isfahan Univ Med Sci, Hlth Management & Econ Reasearch Ctr, Esfahan, IranFatemeh Amiri - Kermanshah Univ Med Sci, Dept Radiol & Nucl Med, Kermanshah, IranDickson A. Amugsi - African Populat & Hlth Res Ctr, Maternal & Child Wellbeing, Nairobi, KenyaRobert Ancuceanu - Carol Davila Univ Med & Pharm, Dept Pharm, Bucharest, RomaniaDeanna Anderlini - The University of QueenslandJason A. Anderson - University of WashingtonCatalina Liliana Andrei - Carol Davila Univ Med & Pharm, Dept Cardiol, Bucharest, RomaniaTudorel Andrei - Bucharest Univ Econ Studies, Dept Stat & Econometr, Bucharest, RomaniaColin Angus - University of SheffieldMina Anjomshoa - Rafsanjan Univ Med Sci, Social Determinants Hlth Res Ctr, Rafsanjan, IranFereshteh Ansari - Tabriz Univ Med Sci, Res Ctr Evidence Based Med, Tabriz, IranAlireza Ansari-Moghaddam - Zahedan Univ Med Sci, Dept Epidemiol & Biostat, Zahedan, IranIppazio Cosimo Antonazzo - University of Milano-BicoccaCarl Abelardo T. Antonio - University of the Philippines ManilaCatherine M. Antony - University of WashingtonErnoiz Antriyandarti - Sebelas Maret UniversityDavood Anvari - Mazandaran Univ Med Sci, Dept Parasitol, Sari, IranRazique Anwer - Imam Mohammad ibn Saud Islamic UniversitySeth Christopher Yaw Appiah - Kwame Nkrumah UniversityJalal Arabloo - Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, IranMorteza Arab-Zozani - Birjand Univ Med Sci, Social Determinants Hlth Res Ctr, Birjand, IranFilippo Ariani - Florence (Netherlands)Bahram Armoon - Saveh Univ Med Sci, Social Determinants Hlth Res Ctr, Saveh, IranJohan Arnlov - Karolinska InstitutetAfsaneh Arzani - Babol Univ Med Sci, Sch Nursing & Midwifery, Babol, IranMehran Asadi-Aliabadi - Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Tehran, IranAli A. Asadi-Pooya - Shiraz UniversityCharlie Ashbaugh - University of WashingtonMichael Assmus - University of WashingtonZahra Atafar - Kermanshah Univ Med Sci, Social Dev & Hlth Promot Res Ctr, Kermanshah, IranDesta Debalkie Atnafu - Bahir Dar UniversityMaha Moh'd Wahbi Atout - Philadelphia Univ, Fac Nursing, Amman, JordanFloriane Ausloos - University of LiègeMarcel Ausloos - Bucharest Univ Econ Studies, Dept Stat & Econometr, Bucharest, RomaniaBeatriz Paulina Ayala Quintanilla - La Trobe UniversityGetinet Ayano - Curtin UniversityMartin Amogre Ayanore - Univ Hlth & Allied Sci, Dept Hlth Policy Planning & Management, Ho, GhanaSamad Azari - Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, IranGhasem Azarian - Hamadan Univ Med Sci, Dept Environm Hlth Engn, Hamadan, IranZelalem Nigussie Azene - University of GondarAlaa Badawi - Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, CanadaGBD 2019 Risk Factors CollaboratorsDavid C Schwebel - Research Administration
- Resource Type
- Journal article
- Publication Details
- The Lancet (British edition), Vol.396(10258), pp.1223-1249
- DOI
- 10.1016/S0140-6736(20)30752-2
- PMID
- 33069326
- PMCID
- PMC7567026
- NLM abbreviation
- Lancet
- ISSN
- 0140-6736
- eISSN
- 1474-547X
- Publisher
- Elsevier
- Number of pages
- 27
- Grant note
- SCAF/15/02 / NRS Senior Clinical Fellowship Department of Health 18K10082 / Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) CP18/00074 / Spanish Ministry of Science, Innovation and Universities Miguel Servet grant (Instituto de Salud Carlos III/ESF, EU) 175087 / Ministry of Education, Science and Technological Development of the Republic of Serbia; Ministry of Education, Science & Technological Development, Serbia Centro de Investigacion en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain Italian Ministry of Health (Ricerca Corrente, Fondazione Istituto Neurologico C Besta, Linea 4 -Outcome Research: dagli Indicatori alle Raccomandazioni Cliniche) MR/R024227/1; MC_UU_12017/13; MC_UU_00022/2; MC_UU_12017/15; MR/M015084/1; MR/S011676/1 / Medical Research Council; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) R21AG032572; R03AG043052; R01 AG030153 / National Institute on Aging, a division of the NIH Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award - German Federal Ministry of Education and Research
- Language
- English
- Date published
- 10/17/2020
- Academic Unit
- Research Administration
- Record Identifier
- 9984949190702771
Metrics
9 Record Views